THE Department of Health recently reported the case of a patient who was severely ill with a new strain of A(H1N1) influenza (swine flu) and died despite being promptly treated with the antiviral drug oseltamivir, which is sold under the trade name Tamiflu.
The case will be investigated to determine if the patient died because the virus was resistant to the drug. One way or another, however, the patient’s death should serve as a reminder that Tamiflu is not a panacea.
On Aug. 21, the WHO issued guidelines for the use of antivirals in the treatment of patients infected with the A(H1N1) pandemic virus. The document stated that most patients infected with the virus experienced typical influenza symptoms and recovered fully within a week, even without medical treatment. That being the case, healthy patients who fall ill but do not suffer complications need not be treated with antiviral drugs.
For severely ill patients and those whose condition begins to deteriorate, the WHO recommends treatment with oseltamivir as soon as possible, preferably within 48 hours after serious symptoms appear.
Dangerous symptoms listed include shortness of breath or difficulty breathing, turning blue, bloody sputum, chest pain, high fever persisting beyond three days and low blood pressure.
Among A(H1N1) patients, treatment with oseltamivir can alleviate symptoms and speed up recovery, just as with seasonal influenza patients. While some experts consider it best to administer the medicine to all confirmed A(H1N1) patients within 48 hours, the WHO guidelines recommend that antivirals only be given if patients exhibit severe symptoms. This recommendation is probably based on concern that overuse of the drug will greatly increase the possibility of drug-resistant virus strains appearing.
The WHO’s Aug. 21 update on this year’s H1N1 pandemic says that the health body had been notified of 12 cases of oseltamivir-resistant strains worldwide. These were all isolated cases arising from mutations in the virus, and there were no apparent epidemiological links between them, nor is there any evidence of onward transmission from these cases.
Even so, several oseltamivir-resistant strains of seasonal H1N1 influenza have appeared over the past few years. Since none of the drug-resistant strains that have been isolated are highly infectious, they do not pose a significant risk to public health security. Since the new, pandemic influenza strain is an H1N1 variant, it would not be surprising if drug-resistant strains were to arise as a result of nonessential use of oseltamivir.
In Taiwan, regulations on the use of oseltamivir have been relaxed, making it likely that cases of resistance to the drug will occur. The danger is that a highly infectious, drug-resistant strain of the pandemic virus may appear and spread rapidly. In that case, it would be necessary to treat patients with the other known effective antiviral drug, zanamivir (trade name Relenza), instead.
Liou Pei-pai is a former director of the Taiwan Animal Health Research Institute.
TRANSLATED BY JULIAN CLEGG
From the Iran war and nuclear weapons to tariffs and artificial intelligence, the agenda for this week’s Beijing summit between US President Donald Trump and Chinese President Xi Jinping (習近平) is packed. Xi would almost certainly bring up Taiwan, if only to demonstrate his inflexibility on the matter. However, no one needs to meet with Xi face-to-face to understand his stance. A visit to the National Museum of China in Beijing — in particular, the “Road to Rejuvenation” exhibition, which chronicles the rise and rule of the Chinese Communist Party — might be even more revealing. Xi took the members
The Chinese Nationalist Party (KMT) and the Taiwan People’s Party (TPP) on Friday used their legislative majority to push their version of a special defense budget bill to fund the purchase of US military equipment, with the combined spending capped at NT$780 billion (US$24.78 billion). The bill, which fell short of the Executive Yuan’s NT$1.25 trillion request, was passed by a 59-0 margin with 48 abstentions in the 113-seat legislature. KMT Chairwoman Cheng Li-wun (鄭麗文), who reportedly met with TPP Chairman Huang Kuo-chang (黃國昌) for a private meeting before holding a joint post-vote news conference, was said to have mobilized her
The inter-Korean relationship, long defined by national division, offers the clearest mirror within East Asia for cross-strait relations. Yet even there, reunification language is breaking down. The South Korean government disclosed on Wednesday last week that North Korea’s constitutional revision in March had deleted references to reunification and added a territorial clause defining its border with South Korea. South Korea is also seriously debating whether national reunification with North Korea is still necessary. On April 27, South Korean President Lee Jae-myung marked the eighth anniversary of the Panmunjom Declaration, the 2018 inter-Korean agreement in which the two Koreas pledged to
As artificial intelligence (AI) becomes increasingly widespread in workplaces, some people stand to benefit from the technology while others face lower wages and fewer job opportunities. However, from a longer-term perspective, as AI is applied more extensively to business operations, the personnel issue is not just about changes in job opportunities, but also about a structural mismatch between skills and demand. This is precisely the most pressing issue in the current labor market. Tai Wei-chun (戴偉峻), director-general of the Institute of Artificial Intelligence Innovation at the Institute for Information Industry, said in a recent interview with the Chinese-language Liberty Times
RSS